Order Article Reprints

Wang X, Burdzhiev NT, Hu H, Li Y, Li J, Lozanova VV, Kandinska MI, Wang M. Novel Tetrahydroisoquinoline-Based Heterocyclic Compounds Efficiently Inhibit SARS-CoV-2 Infection In Vitro. Viruses. 2023; 15(2):502. https://doi.org/10.3390/v15020502

Wang, Xi, Nikola T. Burdzhiev, Hengrui Hu, Yufeng Li, Jiang Li, Vesela V. Lozanova, Meglena I. Kandinska, and Manli Wang. 2023. "Novel Tetrahydroisoquinoline-Based Heterocyclic Compounds Efficiently Inhibit SARS-CoV-2 Infection In Vitro" Viruses 15, no. 2: 502. https://doi.org/10.3390/v15020502

Wang, X., Burdzhiev, N. T., Hu, H., Li, Y., Li, J., Lozanova, V. V., Kandinska, M. I., & Wang, M. (2023). Novel Tetrahydroisoquinoline-Based Heterocyclic Compounds Efficiently Inhibit SARS-CoV-2 Infection In Vitro. Viruses, 15(2), 502. https://doi.org/10.3390/v15020502